Archives: Agenda
Artificial Intelligence in Pharma
- Generative AI roadmap and latest developments
- Business impact and use cases
- Risks, limitations, and other considerations
- Recommendations
Taming the beast: effective financial management of clinical trials
- Building a cost-effective study framework
- Navigating financial aspects of the vendor selection process
- Effective strategies for forecasting and managing the clinical trial budget
Chairperson’s closing remarks
Morning refreshments and networking
Drug safety, regulations, clinical trials, and DACH region
- Mechanism of pharmacovigilance of medicinal products and drug devices in clinical trials in the DACH region
- Assessment of regulations and responsibilities of key stakeholders
- Interplay between the health authorities and vendors and challenges related to pharmacovigilance
FIRESIDE CHAT Enhancing site accessibility and collaboration in clinical trials to reduce burden on sites
• Understanding the resource constraints faced by trial sites and the impact on their accessibility and participation in clinical studies
• Promoting flexibility in data management by accommodating both paper and electronic platforms based on site preferences, ensuring smoother integration and reduced burden on site staff
• Encouraging open communication with sites to understand their specific needs and preferences
Setting up Clinical Operations in a Startup/Biotech Environment: An agile approach to turn a corner
- Introducing Clinical Operations and GCP in a new Start-up / Biotech environment
- Focusing on the key components to successfully, and within budget, run a study from scratch
- Overcome the challenges of a small team inhouse and efficiently perform the oversight
Lunch and networking with Prize Draw at 14:15
VIRTUAL SESSION Exploring WHO’s new framework for strengthening of trial systems
|